Higher levels of natural killer cells are associated with tuberculosis latency, reports a paper published online this week in Nature. The findings raise the question as to whether natural killer cells might play an active role in controlling tuberculosis infections.
Tuberculosis (TB) is a bacterial disease and a leading cause of infection-related deaths. The majority of TB infections are latent - manifesting, without outward symptoms, in a contained state. It is estimated that a quarter of the world’s population has latent TB, although fewer than 10% of latent TB cases end up progressing to an active state. The immune factors that influence a given individual’s infection outcome, however, are poorly understood.
To investigate the immune state that leads to latency and how that changes if the disease progresses, Yueh-hsiu Chien, Purvesh Khatri, and colleagues conducted studies of various human cohorts combining mass cytometry analysis with an examination of gene expression datasets to identify differences in immune cell populations between uninfected subjects and those with latent or active TB.
They find that latent manifestations of TB are associated with higher numbers of natural killer cells - white blood cells that can kill certain pathogens - with enhanced anti-toxin responses in comparison to uninfected individuals. In subjects with an active infection, levels of natural killer cells were diminished, but abundances returned to baseline levels when the infection was cured. However, the findings cannot prove a causal relationship between natural killer cells and TB latency.
Additionally, the authors show that measurements of natural killer cell levels can be used to determine the activity level and burden of TB infection in a patient’s lungs - a finding that could help to assess disease progression and optimize treatments.
COVID-19: Assessing instances of long COVID in UK health dataNature Communications
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine